[1]
|
Hansen LB, Portman D. Hormone therapy update. Current recommendations for menopausal symptoms. US Pharm 2006;31:86-89.
|
[2]
|
Smith AL, Wein AJ. Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction. Discov Med. 2010;10:500-510.
|
[3]
|
Dennerstein L, Lehert P. Women’s sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause 2004;6:778-785.
|
[4]
|
Reimer A, Johnson L. Atrophic vaginitis: signs, symptoms, and better outcomes. Nurse Pract. 2011;36:22-28.
|
[5]
|
Kingsberg S, Kellogg S, Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy.Int J Womens Health 2010;9:105-111.
|
[6]
|
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
|
[7]
|
Bond S, Horton LS. Management of postmenopausal vaginal symptoms in women.. J Gerontol Nurs. 2010;36:3-7.
|
[8]
|
Lacroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KI, Stefanick MI, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy. JAMA 2011;30:1305-1314.
|
[9]
|
Lowe DA, Baltgalvis KA, Greising SM. Mechanisms behind estrogen's beneficial effect on muscle strength in females. Exerc Sport Sci Rev 2010;38:61-67.
|
[10]
|
Basurto L, Saucedo R, Zarate A, Martinez C, Gamino CE, Reyes E, Hernandez-Valencia M. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogens regimen in postmenopausal women. Ginecol Obstet Invest 2006;61:61-64.
|
[11]
|
Hernández-Valencia M, Córdova-Pérez N, Basurto L, Saucedo R, Vargas C, Vargas A, Ruiz M, Manuel L, Zárate A. Frequency of symptoms of the climacteric syndrome. Ginecol Obstet Mex. 2010;78:232-237.
|
[12]
|
Henderson VW. Action of estrogens in the aging brain: dementia and cognitive aging. Biochim Biophys Acta 2010;1800:1077-1083.
|
[13]
|
Rachon D, Suchecka-Rachon K, Hak L, Mysliwska J. Effects of intranasal 17-? estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. Menopause 2006;5:840-845.
|
[14]
|
Gompel A. Molecular action of estrogens and anti-estrogens. Maturitas 2006;54:313-314.
|
[15]
|
Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Garibaldi S, Genazzani A. Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab 2004;89:4594-4600.
|
[16]
|
The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized, controlled trial. JAMA 2004;291:1701-1712.
|